Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 86

Cyteir slides in $80m

Returning backer Novo was among the investors in a series C round for the synthetic cancer treatment developer that was led by RA Capital Management.

Feb 12, 2021

Enevate recharges with $81m

The vehicle charging technology developer, which counts Sumitomo, LG Chem, Samsung, Bangchak and Lenovo as investors, has now raised $191m in total.

Feb 12, 2021

Labster gets $60m result in series C round

Swisscom Ventures participated in a round that lifted the total raised by the laboratory simulation software provider to $104m.

Feb 12, 2021

Jackpocket scores $50m in series C round

The lottery ticket purchasing app provider said it saw record new user growth last month, as it secured funding from investors including Tegna and Circle K.

Feb 12, 2021

Isotropic measures out $40m

Boeing HorizonX and SES Engineering both strapped themselves into the satellite technology developer's latest round, bringing its overall funding to about $60m.

Feb 12, 2021

RapidSOS rescues $85m in series C round

The AAA, CSAA, Microsoft and Motorola Solutions-backed emergency response software developer’s latest round, led by Insight Partners, brought its total funding to $200m.

Feb 11, 2021

Notch marks $85m series A round

Existing strategic investor Allogene Therapeutics has taken part in an $85m series A round for Notch Therapeutics, which is working on cancer treatments.

Feb 11, 2021

Drug Farm harvests $56m

The WuXi AppTec-backed round will help the hepatitis B drug developer begin human trials for its lead drug candidate.

Feb 11, 2021

Jüsto stacks $65m for series A

The Bimbo and Femsa-backed online grocer has now received over $100m in total, having raised $65m from venture capital investors for its series A round.

Feb 11, 2021

TransThera Biosciences takes in $50m

China Merchants Group participated in a series C-plus round for the cancer and inflammatory disease drug developer.

Feb 11, 2021

© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here